Democrats Aim Subpoena Power at Health Officials

Democrats expect to use their new control of Congress to subpoena witnesses, demand records and hold officials and individuals in contempt as they investigate health-care decisions. Early targets include federal Medicaid cuts, health affordability, and staffing and funding at federal health agencies. Congressional committees hold those powers; the people affected by the decisions will mostly enter the story as witnesses and subjects of policy.

Who Holds the Levers

“You don't just do oversight to raise hell,” said Tim Stretton, director of the Congressional Oversight Initiative at the Project On Government Oversight. “Trying to create some systematic change is arguably more important.” The coming hearings will test whether Congress uses its authority to make changes or mainly stages confrontations over who controls the health apparatus.

The House Oversight, Energy and Commerce, and Ways and Means committees are expected to become early centers of activity, along with the Senate health and Finance committees. For months, Democrats have built a paper trail on possible political interference in vaccine policies and on whether Health Secretary Robert F. Kennedy Jr. benefited financially from vaccine litigation.

Robert Garcia (D-Calif.), the likely incoming House Oversight chair, warned Republicans to “lawyer up” on Tuesday after Democrats flipped control of the House. A former Long Beach mayor, Garcia lost his mother, a frontline health worker, and his stepfather to COVID. He has publicly criticized Kennedy for undermining public health and preventing or delaying needed cures.

Some law firms already advise corporate clients to cooperate with committee staff and limit their exposure to negative headlines from hearings. According to a client alert from law firm Morrison Foerster, the White House has added legal staff to prepare for oversight. The alert said the administration might assert executive privilege over some presidential communications with private parties.

Health Decisions Under Scrutiny

Bernie Sanders is expected to return as chair of the Senate health committee, where he could focus on drug prices and challenge Kennedy over his tenure as health secretary. Hearings on Affordable Care Act markets, drug pricing and hospital billing are likely to draw bipartisan support and include ordinary citizens.

Democrats are also expected to blame Trump administration policies and officials for making Americans worse off. Garcia has said corruption within the administration is responsible for affordability problems. Likely Senate Finance Chair Ron Wyden (D-Ore.) has called President Trump's drug-pricing agreements “sweetheart deals” with the pharmaceutical industry that won't help the vast majority of Americans.

Sanders is expected to bring up internal communications that health committee Democrats obtained from former Centers for Disease Control and Prevention chief medical officer Debra Houry. Democrats say those messages show Kennedy changed vaccine recommendations without expert review and directed a federal vaccine advisory panel's actions to undermine access to vaccines. Some of the activity occurred around the time former CDC director Susan Monarez was ousted over vaccine recommendations; the communications could shed light on whether officials misrepresented the reasons for revising recommendations.

A group of senators, including Wyden and Elizabeth Warren (D-Mass.), has questioned whether Kennedy personally benefited from a $50 million settlement involving Merck's Gardasil human papillomavirus vaccine. Kennedy said during his confirmation process that he divested a contingency-fee interest in certain Gardasil lawsuits. The senators want to know whether his ethics agreement accurately described the arrangement and whether conflicts of interest existed.

House Energy and Commerce Committee Democrats have focused on the Food and Drug Administration blocking publication of studies that showed COVID and shingles vaccines were safe. They contend the action reflects a broader trend of suppressing data that doesn't align with Kennedy's views.

The Limits of the Hearing Room

David Mansdoerfer, a senior health official in the first Trump administration, expects DOGE cuts to be a key focus of Democratic oversight, followed by decisions on vaccines, research grants and health agency budgets. “Outside of some minor procedural issues, I don't see a ton of substantive areas that are anything more than just an oversight hearing YouTube highlight clip,” Mansdoerfer wrote on X.

Morrison Foerster's client alert said the administration and Democrats would choose their battles despite the confrontational rhetoric. Investigations may expose choices made inside government, but the article describes no grassroots or community-organized response to those choices. Hearings are expected to include ordinary citizens. Still, Congress holds subpoena power and decides what gets investigated.

A Department of Health and Human Services spokesperson, Emily Hilliard, said: “Secretary Kennedy has delivered the most sweeping public health reforms in modern history. Oversight hearings will not distract him from serving the American people. He will continue to put prevention at the center of health care to end the chronic disease epidemic and Make America Healthy Again.”